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Investigation On The Involvement Of Reactive Oxygen Species And Mitogen-Activated 
Protein Kinase In Endothelium-Dependent Relaxation In Spontaneously Hypertensive 
Rats 
Billy Kong, Godfrey Man, Susan Leung. The University of Hong Kong, Hong Kong, Hong 
Kong 
 
The endogenous cannabinoid system is up-regulated in the spontaneously hypertensive rat 
(SHR), probably as a compensatory mechanism to oppose the high blood pressure [Bátkai et 
al., 2004; Wheal et al., 2007].  More recently, activation of CB1 receptors is shown to cause 
endothelial cell death through generation of reactive oxygen species (ROS) and activation of 
mitogen-activated protein kinases (MAPK) [Rajesh et al., 2010].  The present study 
investigated whether or not ROS/MAPK is activated in the blood vessels of SHR, and if so, 
whether or not these mechanisms contribute to endothelial dysfunction in this animal model.   
Isometric tension was measured in isolated aortae and superior mesenteric arteries of SHR 
and the normotensive Wistar Kyoto (WKY) rats in organ chambers. Relaxations were 
expressed as percentage (%) of phenylephrine (1 µM)-induced contraction. Endothelium-
dependent relaxations to acetylcholine (1 nM - 100 µM) were not different between aortae of 
WKY rats and SHR at 12 weeks old (n=3), but were significantly reduced in 36 weeks SHR 
aortae (n=3, p<0.05).   Endothelium-independent relaxations to sodium nitroprusside (a nitric 
oxide donor, 100 µM) in aortae of 12 and 36 weeks WKY rats and SHR were not significantly 
different (12 week WKY rats: 99.4 ± 5.4%; 12 weeks SHR: 99.8 ± 1.6%; 36 weeks WKY 
rats:  99.3 ± 1.8%; 36 weeks SHR: 94.0 ± 3.5%; n=3). The impairment of acetylcholine-
induced relaxations in 36 weeks SHR aortae were inhibited by indomethacin (a 
cyclooxygenase inhibitor, 10 µM; n=3, p<0.05) or U0126 (a MAPK inhibitor, 10 µM; n=3, 
p<0.05), but not by the combination of Tiron and diethyldithiocarbamate acid (membrane 
permeable antioxidants, 10 mM and 100 µM, respectively; n=3).  In superior mesenteric 
arteries, endothelium-dependent hyperpolarization-mediated relaxations, but not nitric oxide-
mediated relaxations, to acetylcholine (1 nM - 100 µM) were smaller in 12 weeks SHR than 
in age-matched WKY (n=4-7; p<0.05).  This impairment was not affected by U0126 (n=7), 
PD98056 (a MAPK inhibitor, 10 µM; n=8) or catalase (antioxidant enzyme, 1200 U/ml; n=8). 
There was no significant difference between relaxations to SKA-31 (an activator of 
intermediate- and small-conductance calcium-activated potassium channels, 1 nM - 100 µM) 
in 12 weeks WKY and SHR superior mesenteric arteries (n=4).   Therefore, the present data 
suggest that the mechanisms underlying endothelial dysfunction in SHR are different in 
different blood vessels.  Endothelial dysfunction occurs at an earlier age in mesenteric arteries 
of SHR and this impairment is mainly limited to signalling pathways involved in the initiation 
of endothelium-dependent hyperpolarization.  As SHR ages, endothelium-derived nitric 
oxide-mediated relaxation in aortae is also impaired. This latter endothelial dysfunction is 
attributed to activation of MAPK and cyclooxygenase, but not to the generation of ROS.  
Further experiments will be needed to determine whether or not the activation of MAPK in 
SHR aortae is related to the up-regulation of the cannabinoid system in this hypertensive 
animal. 
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